{"id":29699,"date":"2021-10-08T08:40:27","date_gmt":"2021-10-08T14:40:27","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=29699"},"modified":"2021-10-08T08:41:21","modified_gmt":"2021-10-08T14:41:21","slug":"animal-health-news-notes-for-october-8-2021","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-october-8-2021\/","title":{"rendered":"Not\u00edcias e notas de sa\u00fade animal para 8 de outubro de 2021"},"content":{"rendered":"<p>***********************************<br \/>\n<strong>Brakke Consulting&#039;s <\/strong><br \/>\n<strong>Not\u00edcias e notas de sa\u00fade animal de 8 de outubro de<\/strong><strong> 2021<\/strong><br \/>\n<em>Copyright \u00a9 Brakke Consulting<br \/>\n<\/em><em>Editor: Lynn Fondon DVM MBA<br \/>\n<\/em>************************************<br \/>\nNAS NOTICIAS:<\/p>\n<p><u>Outras not\u00edcias<br \/>\n<\/u>AB Vista<br \/>\nAniV8<br \/>\nAnpario<br \/>\nAvivagen<br \/>\nBetterVet<br \/>\nBoehringer Ingelheim<br \/>\nElanco<br \/>\nEmbarque Veterin\u00e1rio<br \/>\nEquiTrace<br \/>\nFeedworks EUA<br \/>\nFromm Family Foods<br \/>\nFulfillment Advantage Ventures<br \/>\nHBAN<br \/>\nIrrus Investimentos<br \/>\nLaborat\u00f3rios Medgene<br \/>\nLaborat\u00f3rios Newport<br \/>\nPro-Vet<br \/>\nPulse Tecnologias Veterin\u00e1rias<br \/>\nTecnologias de Rastreamento Inteligente<br \/>\nIncubar Stonehaven<br \/>\nSwedencare<br \/>\nVaxxinova<br \/>\nVetPrep<br \/>\nZinpro<br \/>\nZoetis (expans\u00e3o de instala\u00e7\u00f5es)<br \/>\nZoetis (VetScan Imagist)<br \/>\nZomedica Corp<\/p>\n<p><strong>************************************<br \/>\n<\/strong><strong>COMUNICADOS DE NOT\u00cdCIAS DA EMPRESA<\/strong><\/p>\n<ul>\n<li><strong>Zoetis<\/strong> anunciou que est\u00e1 apoiando a crescente demanda por seus anticorpos monoclonais \u2013 Cytopoint, Solensia e Librela \u2013 aumentando sua capacidade de produ\u00e7\u00e3o em Tullamore, na Irlanda. A empresa espera que a constru\u00e7\u00e3o comece no in\u00edcio de 2022, com a instala\u00e7\u00e3o expandida programada para se tornar totalmente operacional at\u00e9 2025. A Zoetis tamb\u00e9m est\u00e1 expandindo sua f\u00e1brica em Nebraska para apoiar o alcance comercial global da Librela<em>. (IHS Markit Connect)<\/em><\/li>\n<li><strong>Zoetis<\/strong> anunciou a adi\u00e7\u00e3o de testes de citologia digital \u00e0 plataforma de tecnologia de diagn\u00f3stico multifuncional Vetscan Imagyst. Com essa inova\u00e7\u00e3o, o Vetscan Imagyst agora emprega uma rede de patologistas remotos especializados, juntamente com a tecnologia de intelig\u00eancia artificial (IA) para testes fecais.<em> (DVM360)<\/em><\/li>\n<li><strong>Elanco Sa\u00fade Animal <\/strong>anunciou que planeja criar sua plataforma de pesquisa e desenvolvimento de microbioma enquanto aprimora seu foco em seu pipeline de sa\u00fade para animais de estima\u00e7\u00e3o em est\u00e1gio avan\u00e7ado. A empresa disse que a mudan\u00e7a criaria uma empresa biofarmac\u00eautica independente e com financiamento privado focada no desenvolvimento de solu\u00e7\u00f5es para a sa\u00fade animal e humana, mas pode manter uma participa\u00e7\u00e3o minorit\u00e1ria na nova entidade. <em>(comunicado de imprensa da empresa)<\/em><\/li>\n<li><strong>Vaxxinova <\/strong>anunciou que adquiriu <strong>Laborat\u00f3rios Newport<\/strong> de <strong>Boehringer Ingelheim Sa\u00fade Animal<\/strong>. A Newport fabrica vacinas sob medida para uma s\u00e9rie de doen\u00e7as em su\u00ednos e bovinos. A empresa tamb\u00e9m fornece aos veterin\u00e1rios e criadores de gado recursos de testes de diagn\u00f3stico, como cultura bacteriol\u00f3gica, teste de suscetibilidade a antibi\u00f3ticos, perfis sorol\u00f3gicos de anticorpos, isolamento de v\u00edrus e histopatologia. Os termos financeiros n\u00e3o foram divulgados.<em> (IHS Markit Connect)<\/em><\/li>\n<li><strong>Zomedica Corp<\/strong>. anunciou que adquiriu o <strong>Pulse Tecnologias Veterin\u00e1rias<\/strong> neg\u00f3cios por $70,9 milh\u00f5es em uma transa\u00e7\u00e3o de a\u00e7\u00f5es em dinheiro. A Pulse Veterinary Technologies ou PulseVet fornece tecnologia de onda de choque eletro-hidr\u00e1ulica para o tratamento de uma ampla variedade de condi\u00e7\u00f5es em pacientes veterin\u00e1rios.<em> (Nasdaq. com)<\/em><\/li>\n<li><strong>Zinpro <\/strong>anunciou o lan\u00e7amento da First Line of Defense, uma nova marca de suplementos alimentares desenvolvida para aumentar a barreira epitelial em reprodutoras, frangos de corte, poedeiras e perus.<em> (IHS Markit Connect)<\/em><\/li>\n<li><strong>Fromm Family Foods<\/strong> emitiu um recall volunt\u00e1rio de cerca de 5.500 caixas de ra\u00e7\u00e3o para c\u00e3es Fromm Shredded pode Entr\u00e9e devido a n\u00edveis potencialmente elevados de vitamina D. Os produtos afetados recolhidos foram distribu\u00eddos em lojas de animais de bairro em todo o pa\u00eds.<em> (Tristatehomepage. com)<\/em><\/li>\n<li><strong>Laborat\u00f3rios Medgene<\/strong> anunciou que recebeu aprova\u00e7\u00e3o regulat\u00f3ria para sua plataforma de vacinas prescritas nos EUA. O USDA Center for Veterinary Biologics (CVB) autorizou a plataforma a desenvolver vacinas su\u00ednas e tamb\u00e9m concedeu \u00e0 empresa autoriza\u00e7\u00e3o de uso emergencial para sua vacina experimental contra o v\u00edrus da doen\u00e7a hemorr\u00e1gica do coelho 2 (RHDV2).<em> (IHS Markit Connect)<\/em><\/li>\n<li><strong>Swedencare<\/strong> anunciou que adquiriu <strong>Fulfillment Advantage Ventures<\/strong> (FAV), uma empresa de log\u00edstica dos EUA focada no setor de com\u00e9rcio eletr\u00f4nico de animais de estima\u00e7\u00e3o por $4,75 milh\u00f5es, incluindo um valor em dinheiro de $2,85 milh\u00f5es e a emiss\u00e3o de 111.553 a\u00e7\u00f5es da Swedencare no valor de $1,9 milh\u00f5es. A FAV gerou $2,8 milh\u00f5es em vendas nos 12 meses de setembro de 2020 a agosto de 2021, com suas pr\u00f3prias marcas diretas ao consumidor gerando $1,3 milh\u00f5es<em>.(IHS Markit Connect)<\/em><\/li>\n<li><strong>Rede Borboleta<\/strong>, Inc. anunciou o lan\u00e7amento do novo ultrassom de segunda gera\u00e7\u00e3o Butterfly iQ+ Vet. <em>(comunicado de imprensa da empresa)<\/em><\/li>\n<li><strong>Feedworks EUA <\/strong>anunciou o lan\u00e7amento do Agolin Ruminant, um aditivo alimentar \u00e0 base de plantas que, segundo a empresa, \u00e9 o primeiro produto certificado pelo Carbon Trust para melhorar a efici\u00eancia alimentar e reduzir o metano ent\u00e9rico, para a ind\u00fastria de latic\u00ednios dos EUA<em>. (alimentos)<\/em><\/li>\n<li><strong>Embarque Veterin\u00e1rio<\/strong>, Inc., anunciou o lan\u00e7amento de seu teste de DNA para c\u00e3es de ra\u00e7a pura. O kit oferece aos propriet\u00e1rios de ra\u00e7a pura informa\u00e7\u00f5es de sa\u00fade acion\u00e1veis e exclusivas que ajudar\u00e3o a determinar planos de diagn\u00f3stico, monitoramento e tratamento que podem ser facilmente compartilhados com um veterin\u00e1rio. <em>(Wagmtv.com)<\/em><\/li>\n<li><strong>AB Vista<\/strong> e <strong>Avivagen<\/strong> anunciaram que firmaram um contrato de fornecimento com a AB Vista. A AB Vista se tornar\u00e1 o parceiro de distribui\u00e7\u00e3o exclusivo de OxC-beta para aves, su\u00ednos, ruminantes (l\u00e1cteos e bovinos) e aquicultura nos Estados Unidos, Brasil e Tail\u00e2ndia. <em>(comunicado de imprensa da empresa)<\/em><\/li>\n<li>Inicializa\u00e7\u00e3o veterin\u00e1ria m\u00f3vel, <strong>BetterVet<\/strong>, anunciou lan\u00e7amentos em novos mercados em San Francisco e Seattle. BetterVet est\u00e1 atualmente dispon\u00edvel nas \u00e1reas da Grande Boston, Filad\u00e9lfia, Pittsburgh, Denver, Austin, Palm Beach e Broward.<em> (nbc29.com)<\/em><\/li>\n<li><strong>Tecnologias de Rastreamento Inteligente<\/strong> apresentou seu novo animal de estima\u00e7\u00e3o Link para a plataforma online da Chewy. O dispositivo vest\u00edvel apresenta rastreamento por GPS, alertas de temperatura, controles de treinamento de vibra\u00e7\u00e3o e tom, lembretes, acesso a registros veterin\u00e1rios e monitoramento e an\u00e1lise de atividades personalizadas. Ele pode ser personalizado para definir uma zona segura para os animais de companhia vagarem. <em>(IHS Markit Connect)<\/em><\/li>\n<li><strong>EquiTrace<\/strong> \u2013 um aplicativo exclusivo para cavalos que combina dados de identidade, GPS e registros m\u00e9dicos usando um scanner, um microchip e um telefone celular \u2013 anunciou que garantiu financiamento de 1,25 milh\u00e3o de euros de <strong>HBAN <\/strong>e <strong>Enterprise Ireland<\/strong> para fazer a empresa crescer e focar na expans\u00e3o global. <em>(comunicado de imprensa da empresa)<\/em><\/li>\n<li><strong>AniV8<\/strong>, desenvolvedora de tecnologia de sensores cl\u00ednicos para diagnosticar e monitorar doen\u00e7as que afetam animais de companhia, anunciou a conclus\u00e3o de sua rodada de financiamento pr\u00e9-semente, que fechou significativamente acima de sua meta original. A rodada de financiamento pr\u00e9-semente foi apoiada por investidores, incluindo<strong> Irrus Investimentos; Pro-Vet; <\/strong>e <strong>Incubar Stonehaven<\/strong>.<em> (comunicado de imprensa da empresa)<\/em><\/li>\n<li><strong>Dalan Sa\u00fade Animal<\/strong>, Inc., uma empresa de biotecnologia que desenvolve vacinas para animais de produ\u00e7\u00e3o da nova era, anunciou que fechou financiamento para uma rodada inicial de $1,9 milh\u00e3o. Este financiamento acelera o desenvolvimento da empresa e as atividades comerciais para o lan\u00e7amento de uma vacina inovadora contra abelhas voltada para a loque americana, uma doen\u00e7a altamente contagiosa que amea\u00e7a as colm\u00e9ias em todo o mundo. <em>(PRNewswire)<\/em><\/li>\n<li><strong>VetPrep<\/strong>, fornecedora de prepara\u00e7\u00e3o para exames para estudantes de veterin\u00e1ria, anunciou a Vetcetera, uma comunidade on-line projetada especificamente para veterin\u00e1rios aprimorarem suas pr\u00e1ticas e carreiras por meio da educa\u00e7\u00e3o. Por meio de uma associa\u00e7\u00e3o, os profissionais veterin\u00e1rios ter\u00e3o acesso \u00e0 educa\u00e7\u00e3o continuada aprovada pelo RACE por meio de uma combina\u00e7\u00e3o de webinars ao vivo e v\u00eddeos sob demanda.<em> (PRNewswire)<\/em><\/li>\n<li>Reino Unido <strong>Anpario<\/strong> anunciou o lan\u00e7amento de Optomega Algae, um suplemento de \u00e1cido graxo \u00f4mega-3 na forma de um p\u00f3 seco e fluido. Optomega Algae foi desenvolvido para uso em todas as esp\u00e9cies, mas \u00e9 direcionado a animais reprodutores e produtores que fornecem carne, leite e ovos enriquecidos contendo n\u00edveis mais altos de \u00e1cidos graxos \u00f4mega-3. <em>\u00a0(IHS Markit Connect)<\/em><\/li>\n<\/ul>\n<p>***********************************<br \/>\n<strong>RASTREADOR DE PRE\u00c7O DE A\u00c7\u00d5ES DE SA\u00daDE ANIMAL<\/strong><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-29700\" src=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2021\/10\/Stock-Table-10.7.jpg\" alt=\"\" width=\"614\" height=\"446\" srcset=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2021\/10\/Stock-Table-10.7.jpg 614w, https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2021\/10\/Stock-Table-10.7-480x348.jpg 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 614px, 100vw\" \/><\/p>\n<p>***********************************<br \/>\n<strong>NOT\u00cdCIAS DE SA\u00daDE ANIMAL<\/strong><\/p>\n<ul>\n<li>ESTADOS UNIDOS \u2013 PESQUISA DE PSA O Servi\u00e7o de Pesquisa Agr\u00edcola do USDA anunciou que uma de suas candidatas a vacina contra o V\u00edrus da Peste Su\u00edna Africana (ASF) demonstrou prevenir e proteger efetivamente os su\u00ednos criados na Europa e na \u00c1sia contra a atual cepa asi\u00e1tica circulante do v\u00edrus. A pesquisa, que demonstra que a vacina candidata pode ser produzida comercialmente, mantendo sua efic\u00e1cia vacinal, foi publicada na revista <em>Doen\u00e7as transfronteiri\u00e7as e emergentes. (alimentos)<\/em><\/li>\n<li>EUA \u2013 ORIENTA\u00c7\u00c3O DA FDA A FDA emitiu quatro documentos de orienta\u00e7\u00e3o final para promover abordagens inovadoras para o desenvolvimento de medicamentos para animais: orienta\u00e7\u00e3o final para a ind\u00fastria (GFI) #265, \u201c<a href=\"https:\/\/lnks.gd\/l\/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDEsInVyaSI6ImJwMjpjbGljayIsImJ1bGxldGluX2lkIjoiMjAyMTEwMDUuNDY4OTkyNDEiLCJ1cmwiOiJodHRwczovL3d3dy5mZGEuZ292L3JlZ3VsYXRvcnktaW5mb3JtYXRpb24vc2VhcmNoLWZkYS1ndWlkYW5jZS1kb2N1bWVudHMvY3ZtLWdmaS0yNjUtdXNlLWRhdGEtZm9yZWlnbi1pbnZlc3RpZ2F0aW9uYWwtc3R1ZGllcy1zdXBwb3J0LWVmZmVjdGl2ZW5lc3MtbmV3LWFuaW1hbC1kcnVncz91dG1fbWVkaXVtPWVtYWlsJnV0bV9zb3VyY2U9Z292ZGVsaXZlcnkifQ.Pu8dLpjDjqEmIKlNB22IgBNvtcPzWvnb2Qh_Bc7Itl0\/s\/1256202605\/br\/113368834961-l\">Uso de dados de estudos de investiga\u00e7\u00e3o estrangeiros para apoiar a efic\u00e1cia de novas drogas animais<\/a>\u201d; orienta\u00e7\u00e3o final para a ind\u00fastria (GFI) #266, \u201c<a href=\"https:\/\/lnks.gd\/l\/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDIsInVyaSI6ImJwMjpjbGljayIsImJ1bGxldGluX2lkIjoiMjAyMTEwMDUuNDY4OTkyNDEiLCJ1cmwiOiJodHRwczovL3d3dy5mZGEuZ292L3JlZ3VsYXRvcnktaW5mb3JtYXRpb24vc2VhcmNoLWZkYS1ndWlkYW5jZS1kb2N1bWVudHMvY3ZtLWdmaS0yNjYtdXNlLXJlYWwtd29ybGQtZGF0YS1hbmQtcmVhbC13b3JsZC1ldmlkZW5jZS1zdXBwb3J0LWVmZmVjdGl2ZW5lc3MtbmV3LWFuaW1hbC1kcnVncz91dG1fbWVkaXVtPWVtYWlsJnV0bV9zb3VyY2U9Z292ZGVsaXZlcnkifQ.IB_c-hlNjo5dgsqhRjG_ICBd0b0TbPMGhLQFz76_Apo\/s\/1256202605\/br\/113368834961-l\">Uso de dados do mundo real e evid\u00eancias do mundo real para apoiar a efic\u00e1cia de novos medicamentos para animais<\/a>\u201d; orienta\u00e7\u00e3o final para a ind\u00fastria (GFI) #267, \u201c<a href=\"https:\/\/lnks.gd\/l\/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDMsInVyaSI6ImJwMjpjbGljayIsImJ1bGxldGluX2lkIjoiMjAyMTEwMDUuNDY4OTkyNDEiLCJ1cmwiOiJodHRwczovL3d3dy5mZGEuZ292L3JlZ3VsYXRvcnktaW5mb3JtYXRpb24vc2VhcmNoLWZkYS1ndWlkYW5jZS1kb2N1bWVudHMvY3ZtLWdmaS0yNjctYmlvbWFya2Vycy1hbmQtc3Vycm9nYXRlLWVuZHBvaW50cy1jbGluaWNhbC1zdHVkaWVzLXN1cHBvcnQtZWZmZWN0aXZlbmVzcy1uZXctYW5pbWFsP3V0bV9tZWRpdW09ZW1haWwmdXRtX3NvdXJjZT1nb3ZkZWxpdmVyeSJ9.7fqyzxE-z4_Plg1MWlhwUVr6ATMzJtpmezCwXk7MJwI\/s\/1256202605\/br\/113368834961-l\">Biomarcadores e par\u00e2metros substitutos em estudos cl\u00ednicos para apoiar a efic\u00e1cia de novas drogas animais<\/a>\u201d; e orienta\u00e7\u00e3o final para a ind\u00fastria (GFI) #268, \u201c<a href=\"https:\/\/lnks.gd\/l\/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDQsInVyaSI6ImJwMjpjbGljayIsImJ1bGxldGluX2lkIjoiMjAyMTEwMDUuNDY4OTkyNDEiLCJ1cmwiOiJodHRwczovL3d3dy5mZGEuZ292L3JlZ3VsYXRvcnktaW5mb3JtYXRpb24vc2VhcmNoLWZkYS1ndWlkYW5jZS1kb2N1bWVudHMvY3ZtLWdmaS0yNjgtYWRhcHRpdmUtYW5kLW90aGVyLWlubm92YXRpdmUtZGVzaWducy1lZmZlY3RpdmVuZXNzLXN0dWRpZXMtbmV3LWFuaW1hbC1kcnVncz91dG1fbWVkaXVtPWVtYWlsJnV0bV9zb3VyY2U9Z292ZGVsaXZlcnkifQ.-W_IgTYZfscBw_KJ7srZAwWwH51N3yx2LWnQbzuGBZA\/s\/1256202605\/br\/113368834961-l\">Projetos adaptativos e inovadores para estudos de efic\u00e1cia de novas drogas animais<\/a>.\u201d <em>(FDA)<\/em><\/li>\n<\/ul>\n<p>************************************<br \/>\n<strong>PONTO DE VISTA DA BRAKKE CONSULTORIA<\/strong><br \/>\nUm termo que ouvimos muito hoje \u00e9 \u201cA Grande Ren\u00fancia\u201d. Os dados do Bureau of Labor Statistics mostram que \u00e9 real. Em sua pesquisa JOLTS (Pesquisa de Vagas de Emprego e Rotatividade de M\u00e3o-de-Obra), as \u201cDemiss\u00f5es\u201d est\u00e3o em alta (veja o gr\u00e1fico). As sa\u00eddas s\u00e3o volunt\u00e1rias, n\u00e3o aposentadoria, separa\u00e7\u00e3o de indiv\u00edduos de seus empregos.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-29701 size-full aligncenter\" src=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2021\/10\/Newsletter-Picture-10.7.gif\" alt=\"\" width=\"600\" height=\"300\" \/>Provavelmente, existem tr\u00eas raz\u00f5es principais: (1) h\u00e1 muitas vagas de emprego no momento; (2) muitas pessoas reavaliaram cuidadosamente sua carreira durante a pandemia de COVID; e (3) os modelos de home office predominantes durante a pandemia afrouxaram os la\u00e7os entre empregadores e empregados.<\/p>\n<p>Vimos isso refletido em nossa pesquisa de boletim informativo algumas semanas atr\u00e1s, quando os entrevistados relataram menos coes\u00e3o da equipe agora do que antes da pandemia. Ter funcion\u00e1rios saindo em maior n\u00famero \u00e9 perturbador. No entanto, hoje \u00e9 um mercado de vendedores para a m\u00e3o-de-obra. Como resultado, empregadores e funcion\u00e1rios ter\u00e3o que repensar seu relacionamento para maximizar oportunidades e continuidade. Isso ser\u00e1 mais desafiador, pois as equipes passam menos tempo juntas.<\/p>\n<p><em>John Volk<br \/>\n<\/em>***********************************<br \/>\n<strong>SUA VIS\u00c3O <\/strong><\/p>\n<p>Na semana passada, perguntamos: Como voc\u00ea v\u00ea as condi\u00e7\u00f5es de trabalho de sua equipe nos pr\u00f3ximos 12 a 18 meses? Mais da metade dos entrevistados disse que sua empresa implementaria um estilo h\u00edbrido de trabalho remoto e presencial. Cerca de 30% disseram que continuariam a trabalhar em 2022 como em 2021. Menos de 10% disseram que voltariam \u00e0s condi\u00e7\u00f5es de trabalho pr\u00e9-pand\u00eamicas. Uma pequena porcentagem semelhante disse que deixaria para os funcion\u00e1rios escolherem o trabalho presencial ou remoto.<\/p>\n<p><strong>Essa semana<\/strong><\/p>\n<p>Nesta semana, queremos saber se a Grande Ren\u00fancia est\u00e1 afetando voc\u00ea:<a href=\"https:\/\/www.surveymonkey.com\/r\/783FX5S\">\u00a0 <u>A rotatividade de empregos afetou sua organiza\u00e7\u00e3o e voc\u00ea pessoalmente?<\/u><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>*********************************** Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting para 8 de outubro de 2021 Copyright \u00a9 Brakke Editora Consultora: Lynn Fondon DVM MBA ************************************ NAS NOT\u00cdCIAS: Outras Not\u00edcias AB Vista AniV8 Anpario Avivagen BetterVet Boehringer Ingelheim Elanco Embark Veterinary EquiTrace Feedworks EUA Fromm Family Foods Fulfillment Advantage Ventures HBAN Irrus Investments Medgene Labs Newport Laboratories Pro-Vet Pulse Veterinary Technologies Smart Tracking Technologies Stonehaven Incubate Swedencare Vaxxinova VetPrep Zinpro Zoetis (expans\u00e3o das instala\u00e7\u00f5es) Zoetis (VetScan Imagyst ) Zomedica Corp ************************************ COMUNICADOS DE NOT\u00cdCIAS DA EMPRESA A Zoetis anunciou que est\u00e1 apoiando a crescente demanda por seus anticorpos monoclonais \u2013 Cytopoint, Solensia e Librela \u2013 aumentando a sua capacidade de produ\u00e7\u00e3o em Tullamore, na Irlanda. A empresa espera que a constru\u00e7\u00e3o comece no in\u00edcio de 2022, com a instala\u00e7\u00e3o expandida programada para se tornar totalmente operacional at\u00e9 2025. A Zoetis tamb\u00e9m est\u00e1 expandindo sua unidade de fabrica\u00e7\u00e3o em Nebraska para apoiar o alcance comercial global da Librela. (IHS Markit Connect) Zoetis anunciou a adi\u00e7\u00e3o de testes de citologia digital \u00e0 plataforma de tecnologia de diagn\u00f3stico multifuncional Vetscan Imagyst. Com esta inova\u00e7\u00e3o, a Vetscan Imagyst agora emprega uma rede de patologistas remotos especializados, juntamente com tecnologia de intelig\u00eancia artificial (IA) para testes fecais. (DVM360) A Elanco Animal Health anunciou que planeja criar sua plataforma de pesquisa e desenvolvimento de microbioma \u00e0 medida que aprimora seu foco em seu pipeline de sa\u00fade para animais de estima\u00e7\u00e3o em est\u00e1gio avan\u00e7ado. A empresa disse que a mudan\u00e7a criaria uma empresa biofarmac\u00eautica independente e com financiamento privado<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-october-8-2021\/\" class=\"view-full-post-btn\">Ver postagem completa<\/a><\/div>\n<p>;<\/p>","protected":false},"author":19,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-29699","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-october-8-2021\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"*********************************** Brakke Consulting&#8217;s Animal Health News &amp; Notes for October 8, 2021 Copyright \u00a9 Brakke Consulting Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: Other News AB Vista AniV8 Anpario Avivagen BetterVet Boehringer Ingelheim Elanco Embark Veterinary EquiTrace Feedworks USA Fromm Family Foods Fulfillment Advantage Ventures HBAN Irrus Investments Medgene Labs Newport Laboratories Pro-Vet Pulse Veterinary Technologies Smart Tracking Technologies Stonehaven Incubate Swedencare Vaxxinova VetPrep Zinpro Zoetis (facility expansion) Zoetis (VetScan Imagyst) Zomedica Corp ************************************ COMPANY NEWS RELEASES Zoetis announced it is supporting growing demand for its monoclonal antibodies &#8211; Cytopoint, Solensia and Librela &#8211; by increasing its production capacity in Tullamore, Ireland. The firm expects construction to commence in early 2022, with the expanded facility scheduled to become fully operational by 2025. Zoetis is also expanding its manufacturing site in Nebraska to support the global commercial reach of Librela. (IHS Markit Connect) Zoetis announced the addition of digital cytology testing to the Vetscan Imagyst multi-purpose diagnostics technology platform. With this innovation, Vetscan Imagyst now employs a network of expert remote pathologists along with artificial intelligence (AI) technology for fecal testing. (DVM360) Elanco Animal Health announced that it plans to carve out its microbiome research-and-development platform as it sharpens its focus on its late-stage pet-health pipeline. The company said the move would create a privately funded, independent biopharmaceutical companyView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-october-8-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2021-10-08T14:40:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-10-08T14:41:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2021\/10\/Stock-Table-10.7.jpg\" \/>\n<meta name=\"author\" content=\"Amanda McDavid\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Amanda McDavid\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/\"},\"author\":{\"name\":\"Amanda McDavid\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\"},\"headline\":\"Animal Health News &#038; Notes for October 8, 2021\",\"datePublished\":\"2021-10-08T14:40:27+00:00\",\"dateModified\":\"2021-10-08T14:41:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/\"},\"wordCount\":1452,\"image\":{\"@id\":\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2021\/10\/Stock-Table-10.7.jpg\",\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/\",\"url\":\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2021\/10\/Stock-Table-10.7.jpg\",\"datePublished\":\"2021-10-08T14:40:27+00:00\",\"dateModified\":\"2021-10-08T14:41:21+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/#primaryimage\",\"url\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2021\/10\/Stock-Table-10.7.jpg\",\"contentUrl\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2021\/10\/Stock-Table-10.7.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News &#038; Notes for October 8, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\",\"name\":\"Amanda McDavid\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/amanda\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-october-8-2021\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"*********************************** Brakke Consulting&#8217;s Animal Health News &amp; Notes for October 8, 2021 Copyright \u00a9 Brakke Consulting Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: Other News AB Vista AniV8 Anpario Avivagen BetterVet Boehringer Ingelheim Elanco Embark Veterinary EquiTrace Feedworks USA Fromm Family Foods Fulfillment Advantage Ventures HBAN Irrus Investments Medgene Labs Newport Laboratories Pro-Vet Pulse Veterinary Technologies Smart Tracking Technologies Stonehaven Incubate Swedencare Vaxxinova VetPrep Zinpro Zoetis (facility expansion) Zoetis (VetScan Imagyst) Zomedica Corp ************************************ COMPANY NEWS RELEASES Zoetis announced it is supporting growing demand for its monoclonal antibodies &#8211; Cytopoint, Solensia and Librela &#8211; by increasing its production capacity in Tullamore, Ireland. The firm expects construction to commence in early 2022, with the expanded facility scheduled to become fully operational by 2025. Zoetis is also expanding its manufacturing site in Nebraska to support the global commercial reach of Librela. (IHS Markit Connect) Zoetis announced the addition of digital cytology testing to the Vetscan Imagyst multi-purpose diagnostics technology platform. With this innovation, Vetscan Imagyst now employs a network of expert remote pathologists along with artificial intelligence (AI) technology for fecal testing. (DVM360) Elanco Animal Health announced that it plans to carve out its microbiome research-and-development platform as it sharpens its focus on its late-stage pet-health pipeline. The company said the move would create a privately funded, independent biopharmaceutical companyView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-october-8-2021\/","og_site_name":"Brakke Consulting Website","article_published_time":"2021-10-08T14:40:27+00:00","article_modified_time":"2021-10-08T14:41:21+00:00","og_image":[{"url":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2021\/10\/Stock-Table-10.7.jpg","type":"","width":"","height":""}],"author":"Amanda McDavid","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Amanda McDavid","Tempo estimado de leitura":"7 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/"},"author":{"name":"Amanda McDavid","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615"},"headline":"Animal Health News &#038; Notes for October 8, 2021","datePublished":"2021-10-08T14:40:27+00:00","dateModified":"2021-10-08T14:41:21+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/"},"wordCount":1452,"image":{"@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2021\/10\/Stock-Table-10.7.jpg","articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/","url":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/#primaryimage"},"image":{"@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2021\/10\/Stock-Table-10.7.jpg","datePublished":"2021-10-08T14:40:27+00:00","dateModified":"2021-10-08T14:41:21+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/#primaryimage","url":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2021\/10\/Stock-Table-10.7.jpg","contentUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2021\/10\/Stock-Table-10.7.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-october-8-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Animal Health News &#038; Notes for October 8, 2021"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615","name":"Amanda McDavid","url":"https:\/\/brakkeconsulting.com\/pt\/author\/amanda\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/29699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=29699"}],"version-history":[{"count":3,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/29699\/revisions"}],"predecessor-version":[{"id":29704,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/29699\/revisions\/29704"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=29699"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=29699"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=29699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}